Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention.

Bock, O

Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. [electronic resource] - Journal of musculoskeletal & neuronal interactions - 144-8 p. digital

Publication Type: Journal Article

1108-7161


Administration, Oral
Aged
Alendronate--administration & dosage
Arthralgia--chemically induced
Back Pain--chemically induced
Bone Density Conservation Agents--administration & dosage
Cohort Studies
Drug Administration Schedule
Etidronic Acid--administration & dosage
Female
Hemiterpenes--metabolism
Humans
Injections, Intravenous--adverse effects
Lymphocyte Activation--drug effects
Male
Mevalonic Acid--metabolism
Middle Aged
Musculoskeletal Diseases--chemically induced
Organophosphorus Compounds--metabolism
Osteoporosis--drug therapy
Pain--chemically induced
Retrospective Studies
Risedronic Acid
T-Lymphocytes--drug effects